Family Medicine · Austin, TX
NPI
1700849353
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8517 Fm 1826 Bldg 2
Austin, TX, 78737
Phone (512) 416-0044
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
2,719 services
Medicare patients, 2024
489
Average age 76
Drug cost, 2024
$1.3M
5,935 prescriptions
Company payments, 2025
$3,659
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey Cox was code 99214 (office e&m - established), 732 times for 305 patients. In total Geoffrey Cox billed 2,719 services in 77 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 732 | 305 | $77.02 | $56K |
| 99213 Office E&M - Established | Office | 591 | 329 | $51.33 | $30K |
| 17003 Destruction Skin Lesion | Office | 310 | 39 | $4.17 | $1,291 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 279 | 279 | $117.88 | $33K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 148 | 33 | $0.67 | $98.71 |
| 17000 Destruction Skin Lesion | Office | 73 | 48 | $40.66 | $2,968 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 69 | 69 | $35.64 | $2,459 |
| 81002 Clinical Chemistry | Office | 65 | 48 | $3.41 | $222 |
| 99215 Office E&M - Established | Office | 58 | 48 | $115.95 | $6,725 |
| G0102 Prostate cancer screening; digital rectal examination | Office | 40 | 40 | $12.80 | $512 |
| 20552 Musculoskeletal | Office | 37 | 31 | $30.08 | $1,113 |
| 87811 Immunoassay | Office | 33 | 32 | $40.55 | $1,338 |
| 93000 Electrocardiogram | Office | 27 | 26 | $9.65 | $260 |
| 87804 Immunoassay | Office | 22 | 11 | $16.22 | $357 |
| 99212 Office E&M - Established | Office | 17 | 17 | $15.99 | $272 |
By year: 2022 $185K for 2,927 services; 2023 $170K for 2,714 services; 2024 $152K for 2,719 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 65 | 48 | $3.41 | $222 |
| 87811 Immunoassay | 33 | 32 | $40.55 | $1,338 |
| 87804 Immunoassay | 22 | 11 | $16.22 | $357 |
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey Cox prescribed most often to Medicare patients was Rosuvastatin Calcium, with 342 prescriptions and refills. In total Geoffrey Cox wrote 5,935 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 342 | 1,002 | 113 | $4,254 |
| Atorvastatin Calcium Generic | 271 | 755 | 77 | $2,692 |
| Levothyroxine Sodium Generic | 230 | 659 | 66 | $2,784 |
| Amlodipine Besylate Generic | 209 | 554 | 62 | $1,286 |
| Jardiance Empagliflozin | 176 | 454 | 48 | $246K |
| Tamsulosin Hcl Generic | 168 | 493 | 50 | $2,491 |
| Valsartan Generic | 163 | 443 | 47 | $4,028 |
| Duloxetine Hcl Generic | 157 | 322 | 45 | $3,513 |
| Gabapentin Generic | 148 | 272 | 41 | $2,021 |
| Ezetimibe Generic | 137 | 411 | 49 | $3,228 |
| Metoprolol Succinate Generic | 129 | 353 | 44 | $2,489 |
| Trulicity Dulaglutide | 122 | 191 | 23 | $180K |
| Lisinopril Generic | 120 | 360 | 35 | $1,318 |
| Metformin Hcl Generic | 101 | 268 | 28 | $809 |
| Olmesartan Medoxomil Generic | 99 | 269 | 26 | $1,795 |
Brand drugs: 1,122 claims; generic drugs: 4,778 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey Cox $3,659 ($3,659 in general payments such as food, travel and fees) from 31 companies. The largest payer was Lilly USA, LLC with $418.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 23 | $418 |
| Pfizer Inc. PFE | 24 | $390 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $282 |
| GlaxoSmithKline, LLC. GSK | 17 | $271 |
| Amgen Inc. AMGN | 17 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $204 |
| Novo Nordisk Inc NVO | 11 | $203 |
| Supernus Pharmaceuticals, Inc. SUPN | 6 | $195 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $165 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.